1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow MDASI-SP: new trials by email Literature Review of MDASI-SP trials Research Report on MDASI-SP
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers Nivolumab, EKG, MRI Brain and/or spine - Medulloblastoma, Ependymoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 136 | 2017-07-13 | 2026-10-27 |
Brain Neoplasms (1) · Choroid Plexus Neoplasms (1) · Ependymoma (1) · Medulloblastoma (1) · Meningioma (1) · Pinealoma (1) · Spinal Cord Neoplasms (1)
National Cancer Institute (NCI) (1)
United States (1)